Anand Shah

🚨 Postdoc position working with myself and @drAnand_Shah_ on Bronchiectasis innate immunity. If interested and wish to discuss further please email or DM. jobs.nhs.uk/candidate/joba… Grateful for retweet.

🚨 Tonight! 🚨 The next instalment of ERS Vision Live will feature an expert panel discussing antimicrobial resistance. 📅 16 June (18:00–19:00 CEST) 📍 Online Register your free place: bit.ly/3ZfO7dX #antimicrobialresistance #AMR #bronchiectasis #cysticfibrosis

Climate change: shifting boundaries of fungal disease in Europe and beyond. @NormanRhijn @SarahSedik thorax.bmj.com/content/early/…

Great work, so far the largest series on biologics efficacy in #ABPA specifically. 65% response rate in treatment dependent asthma. @MFT_NAC

Pleased to share our paper of the largest real-world cohort assessing effectiveness of biologic therapy in allergic bronchopulmonary aspergillosis #aspergillus #bronchiectasis ⁦@AspergillosisT⁩ ⁦⁦@ImperialInfect⁩ ⁦@ImperialFungal⁩ jaci-inpractice.org/article/S2213-…

A new month a new publication! Check out our latest paper in which we highlight a role for increased NFAT and NFκB signalling in the hyperinflammatory response to Aspergillus in cystic fibrosis 🍄 @DArmstrongJames @ImperialInfect journals.plos.org/plospathogens/…

Just published: our open-access paper showing results of a global survey of healthcare worker views on antimicrobial resistance in lung disease Pleased to help lead this research with @drAnand_Shah_ on behalf of the @EuroRespSoc @Amr_Lung CRC aricjournal.biomedcentral.com/articles/10.11…

Happy to share our new publication exploring how Interferon-gamma rescues dendritic cell calcineurin-dependent responses to Aspergillus fumigatus via Stat3 to Stat1 switching @DArmstrongJames @ProfAnnaReed @ImperialInfect #Aspergillus 🍄 #Immunotherapy cell.com/iscience/fullt…

🚨We are looking for a motivated Research Technician to work on bronchiectasis with myself, @drAnand_Shah_ + excellent team of clinical and non-clinical researchers. Post funded by @The_MRC Details here: imperial.ac.uk/jobs/search-in… …. Deadline 18th Feb 2025. Pls share and retweet!

In the latest ERJ Podcast episode, listen as Chief Editor @ProfJDChalmers speaks to editorial board member Sanjay Chotirmall about articles published in the current issue: channel.ersnet.org/channel-86-erj…

Recruitment for @NACincas progressing; expected to continue until mid 2026. Patients starting azoles for #CPA may be eligible to be randomised to interferon gamma vs standard of care @MFT_NAC @BTSrespiratory @NIHRresearch #immunotherapy @drAnand_Shah_ @drdavidc

ERJ: Fungal lung disease occurs independently or complicates underlying lung disease. Type and severity are determined by host immunity, geography and environment. Next-generation sequencing is revolutionising diagnostic and treatment strategies. bit.ly/3TFwAJ3

Just published: review of mortality in CPA analysing series from multiple countries. Mortality highest in the first year after diagnosis at 15%, and 32% at 5 years. Early recognition and treatment essential. @MFT_NAC @TheLancetInfDis #cpa thelancet.com/journals/lanin…

🚨#RTI2025 Deadline Extended to November 18!🚨 Submit your abstract and join leading experts in Glasgow. Share your insights and help shape the future of respiratory health! 🌟New deadline: November 18 🔗Submit now: rti-forum.org/2025/?page_id=… #CallForAbstracts #RespiratoryResearch

There is an exciting opportunity for a Clinical Research Fellow to take part in a wide range of ongoing research as part of the Infectious Diseases Clinical Research Team at St Mary’s Hospital. Apply below: imperial.ac.uk/jobs/search-jo… @ImperialNHS @ImperialBRC

Getting ready to hear the best way to pursue a career in fungal research with @DArmstrongJames 🍄 🔬 @ImperialInfect @imperialcollege #Fungi #Immunology

Really excited about this project, come and join us in Liverpool to work on new treatments for NETS in Bronchiectasis #respisbest #ers #embarc #bronchuk

First participants recruited into the INCAS study at @MFT_Research ! Randomised trial of interferon gamma in chronic pulmonary aspergillosis. More info here: clinicaltrials.gov/study/NCT05653… @NACincas @MFT_NAC @NIHRresearch #CPA @RBazaz @drAnand_Shah_

Asthma: Moderate/high dose inhaled steroids - uncommonly - cause CVD, pneumonia and PEs. V difficult study to do to avoid bias. Required 2 large datasets and multiple different studies. Patients should only get the ICS dose they need! @Azeem_Majeed atsjournals.org/doi/abs/10.116…

ERS CRCs have highlighted 13 abstracts to be presented at Congress 2024. @beatpcd will present ‘The international registry for primary ciliary dyskinesia reveals regional variation of genotypes & significant genotype-phenotype correlations’. More info: k4.ersnet.org/prod/v2/Front/…